Paediatric burn injuries in Sub Saharan Africa--an overview

R Albertyn1, S W Bickler, H Rode

  • 1Division of Paediatric Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Rondebosch 7700, Cape Town, South Africa.

Insights

Paediatric burn injuries in Sub Saharan Africa are a significant public health issue. Improving burn care requires enhanced education, infrastructure, and supportive government policies for child burn survivors.

Area of Science:

  • Public Health
  • Pediatrics
  • Global Health

Background:

  • Paediatric burn injuries are prevalent in Sub Saharan Africa, resulting in severe outcomes.
  • Existing data on paediatric burns in the region is limited and often inaccurate.
  • Inadequate burn care, infrastructure deficits, and traditional practices exacerbate the problem.

Purpose of the Study:

  • To review the epidemiology of paediatric burns in Africa.
  • To identify associated health problems and environmental risk factors.
  • To propose a strategy for improving burn care and rehabilitation.

Main Methods:

  • Literature review of available data on paediatric burns in Africa.
  • Analysis of epidemiological patterns, health issues, and contributing factors.
  • Formulation of a strategic approach for enhanced burn management.

Main Results:

  • Burn injuries in children are common with significant consequences.
  • Contributing factors include environmental hazards and inadequate healthcare infrastructure.
  • Current burn care, prevention, and rehabilitation efforts are unsatisfactory.

Conclusions:

  • Improving childhood burn management necessitates advancements in education, social support, fiscal resources, and infrastructure.
  • Traditional beliefs and practices are integral to treatment and cannot be disregarded.
  • Governmental support is crucial for the success of burn care initiatives for African children.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...